21.05.2012 • NewsCollaborationcooperationInnopharma Labs

Solvias, Innopharma Labs to Collaborate on PAT Solutions

The business unit process analytical technology (PAT) of the contract service provider Solvias has entered into collaboration with Innopharma Labs, to expand their services in the field of PAT.

The term of this collaboration allows Solvias to distribute Innopharma Labs' recently launched 3D particle characterizer worldwide.

In utilizing the 3D particle characterizer into its process analytical offer, Solvias' clients benefit from reduced formulation development and scale-up time plus increased process understanding and control during commercial manufacture. The eyecon 3D particle characterizer provides clients with high resolution images as well as particle size data in-line and in realtime.

The application will be presented during Achema in Frankfurt from June 18-22 at the Solvias booth N7 in hall 4.2.

 

 

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.